Healthleap has raised $38 million in seed and Series A funding to expand its artificial intelligence platform that reads patient records to identify hospital patients at risk of undiagnosed illnesses. The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, alongside a $30 million Series A led by Hummingbird Ventures. Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, the startup currently deploys its platform in more than 50 hospitals.
The platform connects to electronic health record systems, using language models to extract clinical concepts from written physician notes while combining structured data like lab reports and vitals to flag patients who need further review. By analyzing adult inpatient records each night, the software writes a risk score and dashboard insights into the care team's existing workflow. The system currently screens for conditions such as malnutrition, delirium, aspiration pneumonia, and pressure ulcers.
Over the past year, Healthleap has scaled from three hospital partners to over 50, including major healthcare providers like Penn Medicine, Cedars-Sinai, and Emory Healthcare. The startup sells multi-year contracts based on licensed bed counts and outcome-based pricing, reporting that customers achieve significant financial returns through improved reimbursements and shorter stays. The company plans to direct the new capital toward engineering, product development, and sales.
This funding is important because it highlights the growing commercial traction and clinical deployment of language models in addressing critical, hard-to-diagnose hospital conditions like malnutrition.